David Jayne. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosisAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunologyAntibodies, Monoclonal, Murine-Derived/administration & dosageAntibodies, Monoclonal, Murine-Derived/adverse effectsB-Lymphocytes/drug effectsB-Lymphocytes/immunologyDrug Administration ScheduleDrug Therapy, CombinationHumansImmunologic Factors/administration & dosageImmunologic Factors/adverse effectsImmunosuppressive Agents/administration & dosageRecurrenceRisk AssessmentRituximabSeverity of Illness IndexTime FactorsTreatment Outcome
Substances: See more » Antibodies, Monoclonal, Murine-DerivedImmunologic FactorsImmunosuppressive AgentsRituximab
Year: 2010 PMID: 20671223 DOI: 10.2215/CJN.05500610
Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN: 1555-9041 Impact factor: 8.237